1. Home
  2. CCO vs OCS Comparison

CCO vs OCS Comparison

Compare CCO & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clear Channel Outdoor Holdings Inc.

CCO

Clear Channel Outdoor Holdings Inc.

HOLD

Current Price

$2.08

Market Cap

1.1B

ML Signal

HOLD

Logo Oculis Holding AG Ordinary shares

OCS

Oculis Holding AG Ordinary shares

HOLD

Current Price

$23.99

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCO
OCS
Founded
1995
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
CCO
OCS
Price
$2.08
$23.99
Analyst Decision
Hold
Strong Buy
Analyst Count
6
7
Target Price
$2.10
$39.57
AVG Volume (30 Days)
2.6M
119.4K
Earning Date
02-23-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,569,344,000.00
$991,999.00
Revenue This Year
$6.76
$14.53
Revenue Next Year
$4.42
$691.13
P/E Ratio
N/A
N/A
Revenue Growth
54.21
N/A
52 Week Low
$0.81
$14.00
52 Week High
$2.26
$23.08

Technical Indicators

Market Signals
Indicator
CCO
OCS
Relative Strength Index (RSI) 50.53 73.77
Support Level $2.04 $19.70
Resistance Level $2.17 $22.14
Average True Range (ATR) 0.09 0.89
MACD -0.02 0.28
Stochastic Oscillator 20.00 94.06

Price Performance

Historical Comparison
CCO
OCS

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

Share on Social Networks: